Global Irbesartan Tablets Market Size By Product Type (75 mg Tablets, 150 mg Tablets, 300 mg Tablets), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geographic Scope And Forecast

Irbesartan Tablets Market Size And Forecast

Irbesartan Tablets Market size was valued at USD 3.10 Billion in 2023 and is projected to reach USD 3.85 Billion by 2030, growing at a CAGR of 2.45% from 2024 to 2030.

The increasing prevalence of high blood pressure is driving the Irbesartan Tablets Market. Additionally, Irbesartan is also used to treat kidney problems caused by type 2 diabetes which also fuels the growth of the market. The Global Irbesartan Tablets Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Irbesartan Tablets Market Definition

Irbesartan belongs to the angiotensin receptor blocker (ARBs) class of drugs. It’s used to treat high blood pressure and protect the kidney in hypertensive type 2 diabetics who have laboratory evidence of renal disease. These tablets function by relaxing blood arteries and allowing blood to flow more easily. It comes in the form of the brand-name medicine Avapro, which can be taken with or without food. It’s often used as an optional-choice treatment if you have to stop taking a similar medicine because it gave you a dry, irritating cough. Irbesartan is a prescription drug and it comes as an oral tablet. Irbesartan is a crystalline powder that is white to off-white in color and has a molecular weight of 428.5.

Irbesartan is a drug that can be taken orally and does not require biotransformation to become active. Irbesartan is rapidly and completely absorbed from the oral, with an average absolute bioavailability of 60% to 80%. Some products that may interact with this Irbesartan drug include aliskiren, lithium, and drugs that may increase the level of potassium in the blood (such as ACE inhibitors including benazepril/lisinopril, birth control pills containing drospirenone). The more common side effects that can occur with irbesartan include diarrhea, heartburn, and tiredness. dizziness, especially when standing up after sitting or lying down.

Global Irbesartan Tablets Market Overview

The increasing prevalence of high blood pressure is driving the Irbesartan Tablets Market. Additionally, Irbesartan is also used to treat kidney problems caused by type 2 diabetes which also fuels the growth of the market. Heart disease and stroke, the world’s first and third major causes of death, are both caused by hypertension. Hypertension affects an estimated 26 % of the world’s population, and the prevalence is expected to rise to 29% by 2025, owing mostly to increases in economically developing countries. Hypertension is a major public health concern due to its high prevalence.

The high prevalence of hypertension creates a huge public health burden. In the past three decades, the highest global blood pressure levels have moved from high-income countries to low-income countries in South Asia and sub-Saharan Africa owing to opposite trends, while blood pressure has been determinedly high in central and eastern Europe. Irbesartan acts by inhibiting the action of the hormone angiotensin II. The blood vessels will relax more as a result of this. It also helps the kidneys eliminate excess water and salt. This aids in the reduction of blood pressure and the improvement of renal function.

According to the World Health Organization (WHO), hypertension affects an estimated 1.28 billion persons aged 30 to 79 globally, with the majority (two-thirds) living in low- and middle-income countries. Furthermore, it is estimated that 46% of adults with hypertension are completely unaware of their disease. Hypertension is a major public health concern due to its high prevalence. However, Chills, cold sweats, confusion, dizziness, faintness, or lightheadedness when getting up from a lying or sitting position are some adverse effects of Irbesartan Tablets that may restrain the market expansion. Additionally, the FDA’s voluntary recalls owing to suspects of cancer-causing chemicals and contamination are restraining the growth of the Irbesartan Tablets Market.

Global Irbesartan Tablets MarketSegmentation Analysis

The Global Irbesartan Tablets Market is segmented on the basis of Product Type, Distribution Channel, And Geography.

Irbesartan Tablets Market, By Product Type

• 75 mg Tablets
• 150 mg Tablets
• 300 mg Tablets

Based on Product Type, The market is segmented into 75 mg Tablets, 150 mg Tablets, and 300 mg Tablets. 150 mg Tablets once daily, with or without food, is the usual recommended beginning and maintenance dose. Irbesartan 150 mg once daily is often more effective than 75 mg at controlling blood pressure for 24 hours. However, starting medication with 75 mg may be recommended, especially in hemodialysis patients and those over the age of 75.

Irbesartan Tablets Market, By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Based on Distribution Channel, The market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. The Hospital Pharmacies segment is expected to grow at a significant rate during the forecasted years.

Irbesartan Tablets Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

On the basis of Geography, The Global Irbesartan Tablets Market is classified into North America, Europe, Asia Pacific, and the Rest of the world.

Key Players

The “Global Irbesartan Tablets Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Apotex, Sanofi, Teva, Jiangsu Hengrui Medicine, Taj Pharmaceuticals, Zhuhai Rundu Pharmaceutica, Verdant Life Sciences.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Report Scope

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.